Fibromyalgia and arthritides

Area of Science:

• Rheumatology
• Neuroscience
• Pain Medicine

Background:

• Fibromyalgia (FM) is a prevalent chronic pain syndrome impacting at least 2% of adults.
• FM is characterized by widespread pain, fatigue, sleep disturbances, and distress, often linked to central nervous system (CNS) dysfunction.
• FM frequently co-occurs with conditions like rheumatoid arthritis (RA), spondyloarthritides (SpA), osteoarthritis (OA), and thyroid disease, complicating diagnosis and management.

Purpose of the Study:

• To highlight the importance of understanding central nervous system (CNS) mechanisms in fibromyalgia (FM).
• To emphasize the need for rheumatologists to differentiate between primary and secondary FM.
• To advocate for improved diagnostic guidelines and tools for managing FM, particularly when co-occurring with arthritic conditions.

Main Methods:

• Review of current understanding of FM pathophysiology, focusing on CNS involvement.
• Analysis of the impact of comorbidities on FM presentation and management.
• Discussion of clinical challenges in distinguishing primary vs. secondary FM.

Main Results:

• Emerging evidence points to CNS malfunction as a key factor in increased pain transmission and perception in FM.
• Associated conditions can confound and aggravate FM symptoms, impacting overall patient well-being.
• Accurate differentiation between primary and secondary FM is essential for appropriate treatment.

Conclusions:

• Effective FM management requires a mechanism-based approach addressing both peripheral and central pain pathways.
• Rheumatologists require enhanced guidelines and instruments to accurately diagnose and manage FM, especially in patients with comorbidities.
• Addressing diffuse pain in arthritic patients with FM is critical to improving their quality of life.